Q BioMed Inc. (QBIO)
OTCMKTS: QBIO · Delayed Price · USD
0.0000
0.00 (0.00%)
May 15, 2024, 10:53 AM EDT - Market closed

Q BioMed Income Statement

Millions USD. Fiscal year is Dec - Nov.
Year 2022202120202019201820172016201520142013
Revenue
0.280.20.030000000
Revenue Growth (YoY)
45.38%551.99%--------
Cost of Revenue
0.290.250.330.0500000.040
Gross Profit
-0.01-0.05-0.3-0.050000-0.040
Selling, General & Admin
3.316.2610.974.485.789.275.030.350.040
Research & Development
0.131.071.883.543.243.11.310.600
Other Operating Expenses
0000000000
Operating Expenses
3.447.3412.858.029.0212.376.350.950.040
Operating Income
-3.45-7.39-13.15-8.02-9.02-12.37-6.35-0.95-0.04-0
Interest Income
1.380.510.31.46000000
Interest Expense
1.380.510.31.460.160.760.480.0100
Other Expense / Income
-1.390.850.352.26-0.160.650.340.12--
Pretax Income
-2.05-8.24-13.49-10.28-9.27-14.54-7.17-1.09-0.04-0
Income Tax
-1.340.510.31.460.250.760000
Net Income
-0.72-8.75-13.79-11.74-9.27-14.54-7.17-1.09-0.04-0
Shares Outstanding (Basic)
4527221514109973
Shares Outstanding (Diluted)
4527221514109973
Shares Change
67.13%20.84%47.34%9.50%31.23%18.12%-2.28%39.36%134.25%-
EPS (Basic)
-0.02-0.33-0.62-0.78-0.67-1.39-0.81-0.12-0.01-0.00
EPS (Diluted)
-0.02-0.33-0.62-0.78-0.67-1.39-0.81-0.12-0.01-0.00
Free Cash Flow
1.94-4.3-6.23-4.11-6.95-5.58-1.55-0.09-0.040
Free Cash Flow Per Share
0.04-0.16-0.28-0.27-0.51-0.53-0.17-0.01-0.01-
Gross Margin
-3.16%-26.20%-986.70%-------
Operating Margin
-1211.74%-3777.44%-43818.05%-------
Profit Margin
-251.83%-4472.19%-45961.35%-------
Free Cash Flow Margin
682.75%-2199.44%-20778.14%-------
EBITDA
-0.25-7.34-13.1-7.97-9.02-12.37-6.35-0.95-0.04-0
EBITDA Margin
-88.77%-3751.88%-43651.38%-------
Depreciation & Amortization
0.050.050.050.05000000
EBIT
-0.3-7.39-13.15-8.02------
EBIT Margin
-106.35%-3777.44%-43818.05%-------
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.